BioSpace News Archive

Business

Evogene Reports Second Quarter of 2019 Financial Results

Evogene Ltd., a leading biotechnology company developing novel products for life science markets, announced its financial results for the second quarter ending June 30, 2019.

July 31, 2019
·
7 min read
Deals

Syndax to Announce Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 7, 2019

Syndax Pharmaceuticals, Inc. announced that it will release its second quarter 2019 financial results on Wednesday, August 7, after the close of the U.S. financial markets.

July 31, 2019
·
3 min read
Business

Caprion Biosciences and HistoGeneX Unite Businesses to Create Global Leader in Immune Monitoring and Biomarker Development

Partnership Facilitated by Major Investment from Arsenal Capital Partners

July 31, 2019
·
6 min read
Drug Development

Medicenna Selects its Lead Immuno-Oncology Clinical Candidate, MDNA19, from its IL-2 Superkine Platform

MDNA19 demonstrates robust efficacy and safety with or without checkpoint inhibitors in preclinical models; Clinical studies expected to commence in 2020

July 31, 2019
·
6 min read
Business

Theravance Biopharma, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update

Theravance Biopharma, Inc. reported financial results for the second quarter ended June 30, 2019.

July 31, 2019
·
14 min read
Business

Biological E and GVK BIO Announce Strategic R&D Partnership

GVK BIO, a leading global Contract Research and Development Organisation, and BE Pharmaceuticals Inc, a rapidly growing pharmaceutical company that develops, manufactures and markets complex and critical injectable products, announced a strategic collaboration in drug product development.

July 31, 2019
·
2 min read
Pharm Country

Rocket Pharmaceuticals Announces Participation at the SVB Leerink Spotlight Series: Rare & Genetic Diseases Conference

Rocket Pharmaceuticals, Inc., a leading U.S.-based multi-platform clinical-stage gene therapy company, announces that Gaurav Shah, M.D., Chief Executive Officer and President of Rocket is scheduled to present on Wednesday, August 7, 2019, at 1:30p.m.

July 31, 2019
·
1 min read
Business

Delphinus Medical Technologies Appoints Dr. Rachel Brem to Its Board of Directors

Delphinus Medical Technologies, Inc., the leader in advanced breast ultrasound technology, announced that Rachel Brem, M.D, has joined the company’s board of directors, effective immediately.

July 31, 2019
·
3 min read
Business

BioInvent Announces Selection of First Target Discovered by BioInvent’s Proprietary F.I.R.S.TTM Technology Platform Under Collaboration With Pfizer Inc.

BioInvent International AB announces that Pfizer Inc. has selected the first target under the companies’ cancer immunotherapy research collaboration and license agreement, into which the companies entered in December 2016 to develop antibodies targeting tumor-associated myeloid cells.

July 31, 2019
·
3 min read
Genetown

Vantage Half-Year Review 2019: Pharma and medtech mega-deals mask drop in M&A activity

The report, published today, analyses stock and market performance, M&A and the financing landscape during the first half of 2019

July 31, 2019
·
2 min read